Cyclis Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Cyclis Pharmaceuticals Ownership

Who owns Cyclis Pharmaceuticals?

Cyclis Pharmaceuticals is owned by ArQule. It was acquired on July 17, 2003.

Cyclis Pharmaceuticals Business Overview

Where is Cyclis Pharmaceuticals headquartered?

Cyclis Pharmaceuticals is headquartered in Norwood, Massachusetts.

What sector is Cyclis Pharmaceuticals in?

Cyclis Pharmaceuticals is a life science company.

When was Cyclis Pharmaceuticals founded?

Cyclis Pharmaceuticals was founded in 2001.

Life Science M&A Summary in 2003

Out of 60 sectors in the Mergr database, life science ranked 13 in number of deals in 2003. The largest life science acquisition in 2003 was Pharmacia - which was acquired by Pfizer for $60.0B.

Join Mergr to view all 42 acquisitions of life science companies in 2003, including 14 acquisitions by private equity firms, and 28 by strategics.

Cyclis Pharmaceuticals, Inc.

333 Providence Highway,
Norwood, Massachusetts 02062
United States,

Cyclis is discovering and developing small-molecule cancer drugs based on a novel technology designed to selectively kill cancer cells and preserve normal cells by restoring and activating cellular checkpoints known to be defective in cancers.


 Subscribe to unlock this and 209,497
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.